hTERT, the catalytic component of telomerase, is downregulated in the haematopoietic stem cells of patients with chronic myeloid leukaemia (original) (raw)

• Shet AS, Jahagirdar BN, Verfaillie CM . Chronic myelogenous leukemia: mechanisms underlying disease progression. Leukemia 2002; 16: 1402–1411.
  Article CAS Google Scholar
• Rowley JD . Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293.
  Article CAS Google Scholar
• Kantarjian HM, Keating MJ, Talpaz M, Walters RS, Smith TL, Cork A et al. Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients. Am J Med 1987; 83: 445–454.
  Article CAS Google Scholar
• Martin PJ, Najfeld V, Hansen JA, Penfold GK, Jacobson RJ, Fialkow PJ . Involvement of the B-lymphoid system in chronic myelogenous leukaemia. Nature 1980; 287: 49–50.
  Article CAS Google Scholar
• Allouche M, Bourinbaiar A, Georgoulias V, Consolini R, Salvatore A, Auclair H et al. T cell lineage involvement in lymphoid blast crisis of chronic myeloid leukemia. Blood 1985; 66: 1155–1161.
  CAS PubMed Google Scholar
• Schuh AC, Sutherland DR, Horsfall W, Mills GB, Dube I, Baker MA et al. Chronic myeloid leukemia arising in a progenitor common to T cells and myeloid cells. Leukemia 1990; 4: 631–636.
  CAS PubMed Google Scholar
• Calabretta B, Perrotti D . The biology of CML blast crisis. Blood 2004; 103: 4010–4022.
  Article CAS Google Scholar
• Mughal TI, Goldman JM . Chronic myeloid leukemia: current status and controversies. Oncology (Huntington) 2004; 18: 837–844, 847; discussion 847–850, 853–834.
  Google Scholar
• Blackburn EH . Structure and function of telomeres. Nature 1991; 350: 569–573.
  Article CAS Google Scholar
• Moyzis RK, Buckingham JM, Cram LS, Dani M, Deaven LL, Jones MD et al. A highly conserved repetitive DNA sequence, (TTAGGG)n, present at the telomeres of human chromosomes. Proc Natl Acad Sci USA 1988; 85: 6622–6626.
  Article CAS Google Scholar
• Greider CW, Blackburn EH . Identification of a specific telomere terminal transferase activity in Tetrahymena extracts. Cell 1985; 43 (Part 1): 405–413.
  Article CAS Google Scholar
• Greider CW, Blackburn EH . The telomere terminal transferase of Tetrahymena is a ribonucleoprotein enzyme with two kinds of primer specificity. Cell 1987; 51: 887–898.
  Article CAS Google Scholar
• Kim NW, Piatyszek MA, Prowse KR, Harley CB, West MD, Ho PL et al. Specific association of human telomerase activity with immortal cells and cancer. Science 1994; 266: 2011–2015.
  Article CAS Google Scholar
• Harley CB, Futcher AB, Greider CW . Telomeres shorten during ageing of human fibroblasts. Nature 1990; 345: 458–460.
  Article CAS Google Scholar
• Vaziri H, Dragowska W, Allsopp RC, Thomas TE, Harley CB, Lansdorp PM . Evidence for a mitotic clock in human hematopoietic stem cells: loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857–9860.
  Article CAS Google Scholar
• Smogorzewska A, de Lange T . Regulation of telomerase by telomeric proteins. Annu Rev Biochem 2004; 73: 177–208.
  Article CAS Google Scholar
• Feng J, Funk WD, Wang SS, Weinrich SL, Avilion AA, Chiu CP et al. The RNA component of human telomerase. Science 1995; 269: 1236–1241.
  Article CAS Google Scholar
• Nakamura TM, Morin GB, Chapman KB, Weinrich SL, Andrews WH, Lingner J et al. Telomerase catalytic subunit homologs from fission yeast and human. Science 1997; 277: 955–959.
  Article CAS Google Scholar
• Harrington L, McPhail T, Mar V, Zhou W, Oulton R, Bass MB et al. A mammalian telomerase-associated protein. Science 1997; 275: 973–977.
  Article CAS Google Scholar
• Nakayama J, Tahara H, Tahara E, Saito M, Ito K, Nakamura H et al. Telomerase activation by hTRT in human normal fibroblasts and hepatocellular carcinomas. Nat Genet 1998; 18: 65–68.
  Article CAS Google Scholar
• Weinrich SL, Pruzan R, Ma L, Ouellette M, Tesmer VM, Holt SE et al. Reconstitution of human telomerase with the template RNA component hTR and the catalytic protein subunit hTRT. Nat Genet 1997; 17: 498–502.
  Article CAS Google Scholar
• Counter CM, Meyerson M, Eaton EN, Ellisen LW, Caddle SD, Haber DA et al. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2), the catalytic subunit of telomerase. Oncogene 1998; 16: 1217–1222.
  Article CAS Google Scholar
• Poole JC, Andrews LG, Tollefsbol TO . Activity, function, and gene regulation of the catalytic subunit of telomerase (hTERT). Gene 2001; 269: 1–12.
  Article CAS Google Scholar
• Aisner DL, Wright WE, Shay JW . Telomerase regulation: not just flipping the switch. Curr Opin Genet Dev 2002; 12: 80–85.
  Article CAS Google Scholar
• Bieche I, Nogues C, Paradis V, Olivi M, Bedossa P, Lidereau R et al. Quantitation of hTERT gene expression in sporadic breast tumors with a real-time reverse transcription-polymerase chain reaction assay. Clin Cancer Res 2000; 6: 452–459.
  CAS PubMed Google Scholar
• de Kok JB, van Balken MR, Roelofs RW, van Aarssen YA, Swinkels DW, Klein Gunnewiek JM . Quantification of hTERT mRNA and telomerase activity in bladder washings of patients with recurrent urothelial cell carcinomas. Clin Chem 2000; 46: 2003–2007.
  CAS PubMed Google Scholar
• Dome JS, Chung S, Bergemann T, Umbricht CB, Saji M, Carey LA et al. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor. Cancer Res 1999; 59: 4301–4307.
  CAS PubMed Google Scholar
• Wu KJ, Grandori C, Amacker M, Simon-Vermot N, Polack A, Lingner J et al. Direct activation of TERT transcription by c-MYC. Nat Genet 1999; 21: 220–224.
  Article CAS Google Scholar
• Kyo S, Takakura M, Taira T, Kanaya T, Itoh H, Yutsudo M et al. Sp1 cooperates with c-Myc to activate transcription of the human telomerase reverse transcriptase gene (hTERT). Nucleic Acids Res 2000; 28: 669–677.
  Article CAS Google Scholar
• Zhou XZ, Lu KP . The Pin2/TRF1-interacting protein PinX1 is a potent telomerase inhibitor. Cell 2001; 107: 347–359.
  Article CAS Google Scholar
• Lin J, Blackburn EH . Nucleolar protein PinX1p regulates telomerase by sequestering its protein catalytic subunit in an inactive complex lacking telomerase RNA. Genes Dev 2004; 18: 387–396.
  Article CAS Google Scholar
• Smith S, Giriat I, Schmitt A, de Lange T . Tankyrase, a poly(ADP-ribose) polymerase at human telomeres. Science 1998; 282: 1484–1487.
  Article CAS Google Scholar
• Cook BD, Dynek JN, Chang W, Shostak G, Smith S . Role for the related poly(ADP-Ribose) polymerases tankyrase 1 and 2 at human telomeres. Mol Cell Biol 2002; 22: 332–342.
  Article CAS Google Scholar
• Smith S, de Lange T . Tankyrase promotes telomere elongation in human cells. Curr Biol 2000; 10: 1299–1302.
  Article CAS Google Scholar
• van Steensel B, Smogorzewska A, de Lange T . TRF2 protects human telomeres from end-to-end fusions. Cell 1998; 92: 401–413.
  Article CAS Google Scholar
• Shay JW, Bacchetti S . A survey of telomerase activity in human cancer. Eur J Cancer 1997; 33: 787–791.
  Article CAS Google Scholar
• Hastie ND, Dempster M, Dunlop MG, Thompson AM, Green DK, Allshire RC . Telomere reduction in human colorectal carcinoma and with ageing. Nature 1990; 346: 866–868.
  Article CAS Google Scholar
• Gertler R, Rosenberg R, Stricker D, Friederichs J, Hoos A, Werner M et al. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma. J Clin Oncol 2004; 22: 1807–1814.
  Article CAS Google Scholar
• Ohyashiki JH, Ohyashiki K, Fujimura T, Kawakubo K, Shimamoto T, Iwabuchi A et al. Telomere shortening associated with disease evolution patterns in myelodysplastic syndromes. Cancer Res 1994; 54: 3557–3560.
  CAS PubMed Google Scholar
• Artandi SE, DePinho RA . A critical role for telomeres in suppressing and facilitating carcinogenesis. Curr Opin Genet Dev 2000; 10: 39–46.
  Article CAS Google Scholar
• Bechter OE, Eisterer W, Pall G, Hilbe W, Kuhr T, Thaler J . Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia. Cancer Res 1998; 58: 4918–4922.
  CAS PubMed Google Scholar
• Sieglova Z, Zilovcova S, Cermak J, Rihova H, Brezinova D, Dvorakova R et al. Dynamics of telomere erosion and its association with genome instability in myelodysplastic syndromes (MDS) and acute myelogenous leukemia arising from MDS: a marker of disease prognosis? Leuk Res 2004; 28: 1013–1021.
  Article CAS Google Scholar
• Boultwood J, Fidler C, Shepherd P, Watkins F, Snowball J, Haynes S et al. Telomere length shortening is associated with disease evolution in chronic myelogenous leukemia. Am J Hematol 1999; 61: 5–9.
  Article CAS Google Scholar
• Boultwood J, Peniket A, Watkins F, Shepherd P, McGale P, Richards S et al. Telomere length shortening in chronic myelogenous leukemia is associated with reduced time to accelerated phase. Blood 2000; 96: 358–361.
  CAS PubMed Google Scholar
• Brummendorf TH, Holyoake TL, Rufer N, Barnett MJ, Schulzer M, Eaves CJ et al. Prognostic implications of differences in telomere length between normal and malignant cells from patients with chronic myeloid leukemia measured by flow cytometry. Blood 2000; 95: 1883–1890.
  CAS PubMed Google Scholar
• Bock O, Serinsoz E, Schlue J, Kreipe H . Different expression levels of the telomerase catalytic subunit hTERT in myeloproliferative and myelodysplastic diseases. Leuk Res 2004; 28: 457–460.
  Article CAS Google Scholar
• Ohyashiki K, Ohyashiki JH, Iwama H, Hayashi S, Shay JW, Toyama K . Telomerase activity and cytogenetic changes in chronic myeloid leukemia with disease progression. Leukemia 1997; 11: 190–194.
  Article CAS Google Scholar
• Tatematsu K, Nakayama J, Danbara M, Shionoya S, Sato H, Omine M et al. A novel quantitative ‘stretch PCR assay’, that detects a dramatic increase in telomerase activity during the progression of myeloid leukemias. Oncogene 1996; 13: 2265–2274.
  CAS PubMed Google Scholar
• Verstovsek S, Kantarjian H, Manshouri T, Cortes J, Faderl S, Giles FJ et al. Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia. Cancer 2003; 97: 1248–1252.
  Article CAS Google Scholar
• Yamada M, Tsuji N, Nakamura M, Moriai R, Kobayashi D, Yagihashi A et al. Down-regulation of TRF1, TRF2 and TIN2 genes is important to maintain telomeric DNA for gastric cancers. Anticancer Res 2002; 22 (6A): 3303–3307.
  CAS PubMed Google Scholar
• Drummond MW, Hoare SF, Monaghan A, Graham SM, Alcorn MJ, Keith WN et al. Dysregulated expression of the major telomerase components in leukaemic stem cells. Leukemia 2005; 19: 381–389.
  Article CAS Google Scholar
• Colgin LM, Wilkinson C, Englezou A, Kilian A, Robinson MO, Reddel RR . The hTERTalpha splice variant is a dominant negative inhibitor of telomerase activity. Neoplasia 2000; 2: 426–432.
  Article CAS Google Scholar
• Hiyama K, Hirai Y, Kyoizumi S, Akiyama M, Hiyama E, Piatyszek MA et al. Activation of telomerase in human lymphocytes and hematopoietic progenitor cells. J Immunol 1995; 155: 3711–3715.
  CAS PubMed Google Scholar
• Bitisik O, Yavuz S, Yasasever V, Dalay N . Telomerase activity in patients with chronic myeloid leukemia and lymphoma. Res Commun Mol Pathol Pharmacol 2000; 107: 3–12.
  CAS PubMed Google Scholar
• Broccoli D, Young JW, de Lange T . Telomerase activity in normal and malignant hematopoietic cells. Proc Natl Acad Sci USA 1995; 92: 9082–9086.
  Article CAS Google Scholar
• Li G, Song YH, Qian LS, Ma XT, Wu KF . Telomerase: obviously activated in the accelerated phase of chronic myeloid leukemia. Haematologica 2000; 85: 1222–1224.
  CAS PubMed Google Scholar
• Bakalova R, Ohba H, Zhelev Z, Kubo T, Fujii M, Ishikawa M et al. Antisense inhibition of Bcr-Abl/c-Abl synthesis promotes telomerase activity and upregulates tankyrase in human leukemia cells. FEBS Lett 2004; 564: 73–84.
  Article CAS Google Scholar
• Avilion AA, Piatyszek MA, Gupta J, Shay JW, Bacchetti S, Greider CW . Human telomerase RNA and telomerase activity in immortal cell lines and tumor tissues. Cancer Res 1996; 56: 645–650.
  CAS PubMed Google Scholar
• Blasco MA, Rizen M, Greider CW, Hanahan D . Differential regulation of telomerase activity and telomerase RNA during multi-stage tumorigenesis. Nat Genet 1996; 12: 200–204.
  Article CAS Google Scholar
• Xu D, Gruber A, Peterson C, Pisa P . Telomerase activity and the expression of telomerase components in acute myelogenous leukaemia. Br J Haematol 1998; 102: 1367–1375.
  Article CAS Google Scholar
• Hoang-Vu C, Boltze C, Gimm O, Poremba C, Dockhorn-Dworniczak B, Kohrle J et al. Expression of telomerase genes in thyroid carcinoma. Int J Oncol 2002; 21: 265–272.
  CAS PubMed Google Scholar
• Wu A, Ichihashi M, Ueda M . Correlation of the expression of human telomerase subunits with telomerase activity in normal skin and skin tumors. Cancer 1999; 86: 2038–2044.
  Article CAS Google Scholar
• Koyanagi Y, Kobayashi D, Yajima T, Asanuma K, Kimura T, Sato T et al. Telomerase activity is down regulated via decreases in hTERT mRNA but not TEP1 mRNA or hTERC during the differentiation of leukemic cells. Anticancer Res 2000; 20 (2A): 773–778.
  CAS PubMed Google Scholar
• Sagawa Y, Nishi H, Isaka K, Fujito A, Takayama M . The correlation of TERT expression with c-myc expression in cervical cancer. Cancer Lett 2001; 168: 45–50.
  Article CAS Google Scholar
• Latil A, Vidaud D, Valeri A, Fournier G, Vidaud M, Lidereau R et al. htert expression correlates with MYC over-expression in human prostate cancer. Int J Cancer 2000; 89: 172–176.
  Article CAS Google Scholar
• Fujimoto K, Takahashi M . Telomerase activity in human leukemic cell lines is inhibited by antisense pentadecadeoxynucleotides targeted against c-myc mRNA. Biochem Biophys Res Commun 1997; 241: 775–781.
  Article CAS Google Scholar
• van Steensel B, de Lange T . Control of telomere length by the human telomeric protein TRF1. Nature 1997; 385: 740–743.
  Article CAS Google Scholar
• Karlseder J, Smogorzewska A, de Lange T . Senescence induced by altered telomere state, not telomere loss. Science 2002; 295: 2446–2449.
  Article CAS Google Scholar
• Brummendorf TH, Ersoz I, Hartmann U, Balabanov S, Wolke H, Paschka P et al. Normalization of previously shortened telomere length under treatment with imatinib argues against a preexisting telomere length deficit in normal hematopoietic stem cells from patients with chronic myeloid leukemia. Ann NY Acad Sci 2003; 996: 26–38.
  Article Google Scholar
• Neumann F, Teutsch N, Kliszewski S, Bork S, Steidl U, Brors B et al. Gene expression profiling of Philadelphia chromosome (Ph)-negative CD34+ hematopoietic stem and progenitor cells of patients with Ph-positive CML in major molecular remission during therapy with imatinib. Leukemia 2005; 19: 458–460.
  Article CAS Google Scholar
• Counter CM, Avilion AA, LeFeuvre CE, Stewart NG, Greider CW, Harley CB et al. Telomere shortening associated with chromosome instability is arrested in immortal cells which express telomerase activity. EMBO J 1992; 11: 1921–1929.
  Article CAS Google Scholar
• Zhu J, Wang H, Bishop JM, Blackburn EH . Telomerase extends the lifespan of virus-transformed human cells without net telomere lengthening. Proc Natl Acad Sci USA 1999; 96: 3723–3728.
  Article CAS Google Scholar
• Liu J, Baykal A, Fung KM, Thompson-Lanza JA, Hoque A, Lippman SM et al. Human telomerase reverse transcriptase mRNA is highly expressed in normal breast tissues and down-regulated in ductal carcinoma in situ. Int J Oncol 2004; 24: 879–884.
  CAS PubMed Google Scholar
• Klapper W, Krams M, Qian W, Janssen D, Parwaresch R . Telomerase activity in B-cell non-Hodgkin lymphomas is regulated by hTERT transcription and correlated with telomere-binding protein expression but uncoupled from proliferation. Br J Cancer 2003; 89: 713–719.
  Article CAS Google Scholar
• Rudolph KL, Chang S, Lee HW, Blasco M, Gottlieb GJ, Greider C et al. Longevity, stress response, and cancer in aging telomerase-deficient mice. Cell 1999; 96: 701–712.
  Article CAS Google Scholar